These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34341593)

  • 1. All in the family: A comparative look at coronaviruses.
    Ellis J
    Can Vet J; 2021 Aug; 62(8):825-833. PubMed ID: 34341593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam.
    Nguyen TTN; Choo EM; Nakamura Y; Suzuki R; Shiina T; Shin-I T; Fukuta M; Nguyen CT; Nguyen TTT; Nguyen LKH; Hoang VMP; Morita K; Dang DA; Hasebe F; Le TQM; Moi ML
    Int J Infect Dis; 2024 Feb; 139():109-117. PubMed ID: 37984763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses.
    Halfmann PJ; Frey SJ; Loeffler K; Kuroda M; Maemura T; Armbrust T; Yang JE; Hou YJ; Baric R; Wright ER; Kawaoka Y; Kane RS
    EBioMedicine; 2022 Dec; 86():104341. PubMed ID: 36375316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 nonstructural protein 6 from Alpha to Omicron: evolution of a transmembrane protein.
    Feng S; O'Brien A; Chen DY; Saeed M; Baker SC
    mBio; 2023 Aug; 14(4):e0068823. PubMed ID: 37477426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.
    Oberemok VV; Laikova KV; Yurchenko KA; Marochkin NA; Fomochkina II; Kubyshkin AV
    Inflamm Res; 2020 Sep; 69(9):801-812. PubMed ID: 32656668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
    Lvov DK; Alkhovsky SV
    Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antivirals for Broader Coverage against Human Coronaviruses.
    Outteridge M; Nunn CM; Devine K; Patel B; McLean GR
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38275966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complicating Infections Associated with Common Endemic Human Respiratory Coronaviruses.
    Cimolai N
    Health Secur; 2021; 19(2):195-208. PubMed ID: 33186086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2.
    Clayton E; Rohaim MA; Bayoumi M; Munir M
    Adv Exp Med Biol; 2021; 1352():15-31. PubMed ID: 35132592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pervasive RNA Secondary Structure in the Genomes of SARS-CoV-2 and Other Coronaviruses.
    Simmonds P
    mBio; 2020 Oct; 11(6):. PubMed ID: 33127861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving ribonucleocapsid assembly/packaging signals in the genomes of the human and animal coronaviruses: targeting, transmission and evolution.
    Chechetkin VR; Lobzin VV
    J Biomol Struct Dyn; 2022; 40(21):11239-11263. PubMed ID: 34338591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2: The Monster Causes COVID-19.
    Song C; Li Z; Li C; Huang M; Liu J; Fang Q; Cao Z; Zhang L; Gao P; Nie W; Luo X; Kang J; Xie S; Lyu J; Zhu X
    Front Cell Infect Microbiol; 2022; 12():835750. PubMed ID: 35211423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel.
    Ng KW; Faulkner N; Wrobel AG; Gamblin SJ; Kassiotis G
    Semin Immunol; 2021 Jun; 55():101507. PubMed ID: 34716096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cross-reactive immunity to emerging coronaviruses: Implications for novel universal mucosal vaccine design.
    Alturaiki W
    Saudi Med J; 2023 Oct; 44(10):965-972. PubMed ID: 37777266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19: from the structure and replication cycle of SARS-CoV-2 to its disease symptoms and treatment.
    Zawilska JB; Lagodzinski A; Berezinska M
    J Physiol Pharmacol; 2021 Aug; 72(4):. PubMed ID: 34987123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2, aging, and Post-COVID-19 neurodegeneration.
    Strong MJ
    J Neurochem; 2023 Apr; 165(2):115-130. PubMed ID: 36458986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play.
    Souza PFN; Mesquita FP; Amaral JL; Landim PGC; Lima KRP; Costa MB; Farias IR; Lima LB; Montenegro RC
    Int J Biol Macromol; 2021 May; 179():1-19. PubMed ID: 33667553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.